1. Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease. Issue 6 (15th July 2014) Authors: Mazor, Y.; Almog, R.; Kopylov, U.; Ben Hur, D.; Blatt, A.; Dahan, A.; Waterman, M.; Ben‐Horin, S.; Chowers, Y. Journal: Alimentary pharmacology & therapeutics Issue: Volume 40:Issue 6(2014) Page Start: 620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab. Issue 2 (16th November 2016) Authors: Ungar, B.; Kopylov, U.; Engel, T.; Yavzori, M.; Fudim, E.; Picard, O.; Lang, A.; Williet, N.; Paul, S.; Chowers, Y.; Bar‐Gil Shitrit, A.; Eliakim, R.; Ben‐Horin, S.; Roblin, X. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 2(2017) Page Start: 276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Early drug and anti‐infliximab antibody levels for prediction of primary nonresponse to infliximab therapy. Issue 2 (9th November 2017) Authors: Bar‐Yoseph, H.; Levhar, N.; Selinger, L.; Manor, U.; Yavzori, M.; Picard, O.; Fudim, E.; Kopylov, U.; Eliakim, R.; Ben‐Horin, S.; Chowers, Y.; Ungar, B. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 2(2018) Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Editorial: anti‐tumour necrosis factor α antibodies – can efficacy be regained?. Issue 11 (5th May 2017) Authors: Bar‐Yoseph, H.; Chowers, Y. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 11(2017) Page Start: 1473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Editorial: anti‐tumour necrosis factor α antibodies – can efficacy be regained?. Issue 11 (June 2017) Authors: Bar‐Yoseph, H.; Chowers, Y. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 11(2017) Page Start: 1473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0157 Rheumatologic Manifestations in Inflammatory Bowel Disease Patients Referred to the Rheumatology Service in A Tertiary Referral Center. (10th June 2014) Authors: Braun-Moscovici, Y.; Chowers, Y.; Toledano, K.; Markovits, D.; Gralnek, I.; Waterman, M.; Beshara-Garzoz, R.; Dagan, A.; Rozin, A.; Nahir, M.A.; Balbir-Gurman, A. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0207 The input of measuring of infliximab and adalimumab levels and levels of antibodies to these drugs in the management of patients with autoimmune diseases treated with anti tnf monoclonal antibodies. (23rd January 2014) Authors: Braun-Moscovici, Y.; Ben Horin, S.; Dagan, A.; Toledano, K.; Markovits, D.; Saffouri, A.; Beshara, R.; Rozin, A.; Nahir, M. A.; Chowers, Y.; Balbir-Gurman, A. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0509 Upper Gastrointestinal Bleeding is Associated with Significantly Higher Mortality in Systemic Sclerosis Patients. (10th June 2014) Authors: Braun-Moscovici, Y.; Markovits, D.; Gralnek, I.; Toledano, K.; Beshara-Garzoz, R.; Dagan, A.; Rozin, A.; Chowers, Y.; Balbir-Gurman, A. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis. Issue 12 (19th April 2016) Authors: Ungar, B.; Mazor, Y.; Weisshof, R.; Yanai, H.; Ron, Y.; Goren, I.; Waizbard, A.; Yavzori, M.; Fudim, E.; Picard, O.; Loebstein, R.; Kopylov, U.; Dotan, I.; Chowers, Y.; Eliakim, R.; Ben‐Horin, S. Journal: Alimentary pharmacology & therapeutics Issue: Volume 43:Issue 12(2016) Page Start: 1293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron‐containing medicines. Issue 7 (April 2014) Authors: Gomollón, F.; Chowers, Y.; Danese, S.; Dignass, A.; Haagen Nielsen, O.; Lakatos, P. L.; Lees, C. W.; Lindgren, S.; Lukas, M.; Mantzaris, G. J.; Michetti, P.; Moum, B.; Peyrin‐Biroulet, L.; Toruner, M.; van der, J.; Weiss, G.; Stoevelaar, H.; Reinisch, W. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 7(2014) Page Start: 743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗